Physician profile
Murray Lieberman
NPI 1861401846
$2,694.32
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,433 · 2020: $205 · 2022: $26.99 · 2024: $28.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $28.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $28.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,445.01 | 2019 | |
| Ferring Pharmaceuticals INC. | $173.27 | 2019-2020 | |
| Pfizer INC. | $155.10 | 2019 | |
| Abbvie INC. | $146.77 | 2019-2024 | |
| Astellas Pharma US INC | $145.89 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $138.77 | 2019-2020 | |
| Boston Scientific Corporation | $100.84 | 2019 | |
| Antares Pharma, INC. | $76.00 | 2019 | |
| Janssen Biotech, INC. | $68.04 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $68.02 | 2019 | |
| Dendreon Pharmaceuticals LLC | $66.42 | 2019 | |
| Allergan, INC. | $33.05 | 2019 | |
| Sun Pharmaceutical Industries INC. | $24.27 | 2020 | |
| Janssen Scientific Affairs, LLC | $20.16 | 2020 | |
| Ethicon US, LLC | $17.77 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Srs Medical Systems, INC. | $14.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Murray Lieberman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.